Classification
Product TypeIngredient
Product FormFresh (often frozen)
Industry PositionAnimal-derived dietary ingredient (dietary supplement and cosmetic ingredient)
Market
Royal jelly in the United States is primarily positioned as a dietary ingredient used in dietary supplements (e.g., capsules) and some cosmetic/personal-care products. As an FDA-regulated imported food/dietary ingredient, shipments offered for import generally require FDA Prior Notice, and imported foods are subject to FDA compliance checks at entry. For finished dietary supplements manufactured/packed in the U.S., FDA enforces dietary supplement CGMP requirements under 21 CFR Part 111, and failures can render products adulterated. Supply availability and price can be indirectly affected by honey bee health shocks (e.g., Varroa mite–associated colony losses) that disrupt apiculture outputs.
Market RoleDomestic consumer market for a niche apiculture-derived ingredient (dietary supplement and cosmetic uses)
Domestic RoleDietary supplement ingredient used in finished-product manufacturing/packaging subject to U.S. dietary supplement CGMP expectations
Risks
Regulatory Compliance HighFDA CGMP noncompliance for dietary supplements containing royal jelly (e.g., missing or inadequate specifications for identity/purity/strength/composition) can render products adulterated and can trigger warning letters, import scrutiny, and commercial disruption for U.S. sales.Operate under 21 CFR Part 111 with documented component and finished-product specifications, qualified supplier controls/COAs with verification testing, and robust label/claim review prior to market; address FDA observations promptly with CAPA.
Regulatory Compliance MediumMisbranding risk from impermissible disease claims on labels/marketing for royal jelly dietary supplements can provoke FDA objections and enforcement exposure; structure/function claims require substantiation, a mandated disclaimer, and notification to FDA under 21 CFR 101.93/FD&C Act 403(r)(6).Implement pre-release label and website claim clearance; confine claims to substantiated structure/function language and include required disclaimer and timely FDA notification where applicable.
Food Safety MediumRoyal jelly has been associated in medical literature with hypersensitivity reactions (including asthma and anaphylaxis) in some individuals, creating recall/reputational risk and heightened complaint handling needs in the U.S. consumer market.Include clear allergen/bee-product sensitivity cautioning as appropriate, maintain robust adverse-event intake and evaluation processes, and ensure supplier controls reduce contamination/adulteration risk.
Climate MediumU.S. honey bee colony collapses linked to Varroa mites, virus pressure, and miticide resistance can tighten availability of apiculture-derived products and contribute to price and procurement volatility for royal jelly inputs.Diversify approved suppliers and origins, maintain safety stock for critical SKUs, and require documented apiary health management and residue/contaminant monitoring in supplier qualification.
Sustainability- Honey bee health/colony-loss risk (e.g., Varroa destructor–associated virus pressure and miticide resistance) can disrupt apiculture-derived supply availability and increase sourcing volatility.
Standards- USP Dietary Supplement Verification Program (voluntary third-party verification of supplement quality systems and products)
- NSF/ANSI 173 (dietary supplement standard referenced in third-party certification ecosystems)
FAQ
What are the key U.S. compliance pitfalls when selling royal jelly as a dietary supplement?FDA can cite products as adulterated if dietary supplement CGMP controls are inadequate (for example, missing finished-product specifications required under 21 CFR Part 111). FDA also scrutinizes marketing claims—disease-treatment claims are not permitted for supplements, and structure/function claims require substantiation, a required disclaimer, and notification to FDA under 21 CFR 101.93/FD&C Act 403(r)(6).
What is a required step before importing royal jelly (as food/dietary ingredient) into the United States?FDA Prior Notice must be submitted electronically before the shipment arrives in the United States (via CBP’s ABI/ACE interface or FDA’s Prior Notice System Interface, depending on the entry workflow). FDA states that inadequate Prior Notice can lead to refusal and holds at the port of entry.
What is a notable consumer safety risk associated with royal jelly products?Medical case reports and studies have linked royal jelly ingestion to hypersensitivity reactions in some individuals, including asthma and anaphylaxis. This makes clear consumer communication, complaint handling, and strong quality controls important for U.S. market risk management.